UNCY·90466Y202·US·equity·Healthcare - Biotechnology-13D/G
UNCY (UNICYCIVE THERAPEUTICS INC) is held by 28 institutional investors as of Q1 2026. Largest holders: MILLENNIUM MANAGEMENT LLC ($9.2M), CITADEL ADVISORS LLC ($1.6M), GEODE CAPITAL MANAGEMENT, LLC ($1.3M). Net institutional sentiment: Mixed.
See how UNCY's score breaks down across 4 SEC sources
Showing 1-20 of 29
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer